ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,576Medicare Part D Prescriptions Filled, Including Refills

Rank: 220 out of 1000

$436K Total Retail Price of All Prescriptions

Rank: 310 out of 1000

377 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 8,650 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
FUROSEMIDE 460 378 1 7
OMEPRAZOLE 429 335 2 2
LISINOPRIL 412 295 3 5
SIMVASTATIN 393 299 4 3
CARVEDILOL 357 227 5 15
LOVASTATIN 289 203 6 41
PRENATAL PLUS 270 251 10 7 242
METFORMIN HCL ER 256 205 8 44
AMLODIPINE BESYLATE 254 184 9 6
POTASSIUM CHLORIDE 218 185 10 10
ALLOPURINOL 212 171 11 31
METFORMIN HCL 194 130 12 8
LEVOTHYROXINE SODIUM 171 145 13 4
BENAZEPRIL HCL 171 143 13 61
HYDROCHLOROTHIAZIDE 169 91 15 9
HYDRALAZINE HCL 156 87 16 74
WARFARIN SODIUM 155 129 17 22
ENALAPRIL MALEATE 154 123 18 58
TRAMADOL HCL 148 110 19 13
GABAPENTIN 139 96 20 11
METOPROLOL TARTRATE 135 104 21 19
HYDROCODONE-ACETAMINOPHEN 127 121 S3 22 1
CITALOPRAM HBR 118 101 23 17
RANITIDINE HCL 116 94 24 37
NEXIUM 113 69 25 23
CLONIDINE HCL 111 31 26 27
SERTRALINE HCL 108 92 27 26
CLOPIDOGREL 104 93 28 35
PLAVIX 103 91 29 49
DIVALPROEX SODIUM 102 97 30 113
ATENOLOL 99 53 31 24
BENAZEPRIL-HYDROCHLOROTHIAZIDE 98 77 32 175
CRESTOR 97 60 33 30
PRAVASTATIN SODIUM 94 56 34 12
LYRICA 88 35 35 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 13 36 20
VERAPAMIL ER 79 68 37 86
ALENDRONATE SODIUM 79 77 37 57
MEGESTROL ACETATE 78 78 R 39 134
GLIPIZIDE 77 34 40 62
LOSARTAN POTASSIUM 76 55 41 25
AMITRIPTYLINE HCL 76 27 R 41 45
MELOXICAM 73 60 43 14
INSULIN SYRINGE 70 40 44 93
ACTOS 68 34 45 119
DONEPEZIL HCL 66 66 46 32
RISPERIDONE 65 53 47 87
KLOR-CON M20 65 51 47 66
BACLOFEN 65 61 47 129
FAMOTIDINE 64 58 50 88
ATORVASTATIN CALCIUM 63 48 51 18
LATANOPROST 61 56 52 222
NOVOLIN 70-30 61 61 52 160
NAMENDA 61 61 52 43
LANTUS 60 52 55 68
POLYETHYLENE GLYCOL 3350 59 43 56 69
DIOVAN 58 46 57 67
IBUPROFEN 57 28 58 94
HUMULIN 70-30 55 42 59 131
ZOLPIDEM TARTRATE 53 42 60 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.